Background In patients with stable coronary artery disease, it remains unclear whether an
initial management strategy of percutaneous coronary intervention (PCI) with intensive …

Background Among patients with stable coronary disease and moderate or severe ischemia,
whether clinical outcomes are better in those who receive an invasive intervention plus …

Background— Extent and severity of myocardial ischemia are determinants of risk for patients
with coronary artery disease, and ischemia reduction is an important therapeutic goal. The …

Statins (HMG-CoA reductase inhibitors) are used widely for the treatment of hypercholesterolemia.
They inhibit HMG-CoA reductase competitively, reduce LDL levels more than other …

BACKGROUND Recent clinical trials have shown that modification of plasma lipoprotein
concentrations can favorably alter progression of coronary atherosclerosis, but no data exist on …

Background It has not been clearly established whether percutaneous coronary intervention
(PCI) can provide an incremental benefit in quality of life over that provided by optimal …

The American College of Cardiology, Society for Cardiovascular Angiography and Interventions,
Society of Thoracic Surgeons, and American Association for Thoracic Surgery, along …

Although the importance of postexercise nutrient ingestion timing has been investigated for
glycogen metabolism, little is known about similar effects for protein dynamics. Each subject (…

Background In the ISCHEMIA trial, an invasive strategy with angiographic assessment and
revascularization did not reduce clinical events among patients with stable ischemic heart …

Background Tea consumption has been associated with decreased cardiovascular risk, but
potential mechanisms of benefit are ill-defined. While epidemiologic studies suggest that …